Latest News

Recent

July 27, 2015

Thermo Fisher Scientific Unveils New Solutions to Advance the Use of Clinical Testing and Improve Patient Outcomes

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today introduced new instruments and assays to expand the use of clinical testing, enhance laboratory productivity and ultimately improve patient outcomes. The new solutions were unveiled today at the 2015 AACC Annual Meeting and Clinical Lab Expo, Booth 3135, being held at the Georgia World Congress Center in Atlanta, July 26 - 30.

More

July 27, 2015

New Clinical Diagnostic Solutions for Allergy and Autoimmune Testing On Display at AACC

Clinical laboratories performing immunodiagnostic testing now have a wider array of solutions to aid in the diagnosis of allergy and autoimmune diseases.

More

July 27, 2015

Now Available for Antimicrobial Susceptibility Testing, Dalbavancin on FDA-Cleared Microbroth Dilution Susceptibility Plates

The antimicrobial dalbavancin represents one of the latest treatment options for skin infections and is now available on FDA-cleared microbroth dilution susceptibility plates, giving microbiology laboratories the means for susceptibility testing for fastidious Gram-positive organisms that cause acute bacterial skin and skin structure infections (ABSSSIs) in adults.

More

May 13, 2015

Thermo Fisher Scientific introduces two new printers for pathologists

Anatomical pathology professionals can reduce the frequency of patient identification errors with the help of two new Thermo Scientific on-demand printing systems. Whether at the grossing station or performing histology, technicians can save time and avoid errors inherent to hand-labeled cassettes and slides thanks to these two new printers.

More

July 27, 2015

Quality Control of Immunoassay Testing is Now Stable for 5 Years

Clinical chemistry and manufacturing laboratories performing quality control (QC) will now have relief from QC standard lot changes for up to five years.

More

July 27, 2015

Four-Channel HPLC Increases Clinical Throughput Capabilities with Class I Medical Device Listing

Clinical laboratories requiring high-throughput separations for their LC-MS assays now have access to a new four-channel, high-performance liquid chromatography (HPLC) system designed to increase the productivity and efficiency of clinical sample separations, while freeing valuable bench space.

More

June 4, 2015

Now Available for Antimicrobial Susceptibility Testing, ORBACTIV® (Oritavancin) on FDA-Cleared Microbroth Dilution Susceptibility Plates

The new antimicrobial oritavancin represents one of the latest treatment options for skin infections and is now available on FDA-cleared microbroth dilution susceptibility plates, giving microbiology laboratories the means for susceptibility testing of fastidious and non-fastidious gram positive organisms that cause skin infections in adults.

More

May 5, 2015

New ultra-low temperature freezer offers outstanding sustainability, sample protection

More

View all news